1.
全组广泛期小细胞肺癌患者的一般情况和总生存期的单因素分析
Clinical characteristics and univariate analysis of overall survival (OS) of all extensive-stage samll cell lung
| Factor | n (%) | OS (month) | 95%CI (month) | χ2 | P | |
| ECOG PS: Eastern Cooperative Oncology Group performance status | ||||||
| Sex | 0.918 | 0.338 | ||||
| Male | 300 (76.1) | 13.8 | 12.21-15.33 | |||
| Female | 94 (23.9) | 16.5 | 14.36-18.64 | |||
| Age (yr) | 6.936 | 0.008 | ||||
| ≥60 | 232 (58.9) | 13.2 | 10.45-16.02 | |||
| < 60 | 162 (41.1) | 15.4 | 13.66-17.14 | |||
| Smoking history | 2.269 | 0.132 | ||||
| Yes | 297 (75.4) | 13.4 | 11.30-15.45 | |||
| No | 97 (24.6) | 15.6 | 13.63-17.51 | |||
| ECOG PS | 18.963 | < 0.001 | ||||
| 0-1 | 304 (77.2) | 15.6 | 14.00-17.14 | |||
| 2-4 | 90 (22.8) | 9.9 | 5.90-13.96 | |||
| Brain metastasis | 0.435 | 0.510 | ||||
| Yes | 71 (18.0) | 11.8 | 5.92-17.68 | |||
| No | 323 (82.0) | 14.9 | 13.30-16.50 | |||
| Liver metastasis | 28.153 | < 0.001 | ||||
| Yes | 78 (20.0) | 9.3 | 7.60-11.00 | |||
| No | 316 (80.0) | 16.4 | 15.16-17.64 | |||
| Bone metastasis | 20.270 | < 0.001 | ||||
| Yes | 128 (32.5) | 10.0 | 8.26-11.80 | |||
| No | 266 (67.5) | 16.6 | 15.32-17.82 | |||
| Adrenal metastasis | 0.237 | 0.626 | ||||
| Yes | 62 (15.7) | 14.5 | 11.82-17.20 | |||
| No | 332 (84.3) | 14.8 | 13.12-16.54 | |||
| Malignant pleural fluid | 0.045 | 0.832 | ||||
| Yes | 104 (26.4) | 15.5 | 12.83-18.23 | |||
| No | 290 (73.6) | 14.5 | 12.79-16.28 | |||
| Chemotherapy | 41.372 | < 0.001 | ||||
| Yes | 369 (93.7) | 15.1 | 13.43-16.84 | |||
| No | 25 (6.3) | 1.6 | 0.62-2.64 | |||
| Thoracic radiotherapy | 14.017 | < 0.001 | ||||
| Yes | 164 (41.6) | 16.8 | 14.36-19.25 | |||
| No | 230 (58.4) | 12.3 | 9.93-14.73 | |||